Approved · Notification · Phase 1 · decided in 22 days, 24 Feb 2026
Abbott Laboratories, via Badger Merger Sub I, Inc, acquired 100% of the shares in Exact Sciences Corporation. Both US-headquartered global healthcare companies supply oncological diagnostic products in Australia. Abbott is active in diagnostics and medical devices, while Exact Sciences specialises in advanced molecular diagnostics for cancer screening.
Abbott Laboratories ( Abbott ), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation ( Exact Sciences ) through an Agreement and Plan of Merger. Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing. The parties both supply oncological diagnostic products in Australia.